DRMTY.US Dr. Martens plc
- Market cap
- USD 665M
- P/E
- 17.5x
- P/B
- 1.60x
- ROE
- 6.6%
- Dividend yield
- 4.85%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Mar 2026.
Is DRMTY.US undervalued?
Graham numberDRMTY.US trades 11.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Dr. Martens plc fundamental analysis
No fundamental analysis for Dr. Martens plc yet.
Dr. Martens plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Dr. Martens plc
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Full company profileDr. Martens plc financial statements
Dr. Martens plc annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 291M | 349M | 454M | 672M | 773M | 908M | 1.00B | 877M | 788M | 765M |
| Gross Profit | 149M | 186M | 261M | 402M | 471M | 579M | 618M | 575M | 512M | 506M |
| Operating Income | 33.1M | 40.2M | 68.0M | 143M | 113M | 228M | 181M | 126M | 56.1M | 140M |
| EBITDA | 36.7M | 46.0M | 77.8M | 171M | 143M | 265M | 235M | 196M | 111M | 142M |
| Net Income | -11.3M | -5.70M | 17.2M | 74.8M | 34.7M | 181M | 129M | 69.2M | 4.50M | 23.8M |
| EPS | -0.02 | -0.02 | 0.07 | 0.43 | 0.07 | 0.36 | 0.26 | 0.14 | 0.01 | 0.05 |
| Balance Sheet | ||||||||||
| Total Assets | 420M | 446M | 450M | 657M | 653M | 859M | 993M | 952M | 890M | 877M |
| Total Liabilities | 438M | 475M | 459M | 586M | 502M | 531M | 588M | 584M | 523M | 516M |
| Shareholders' Equity | -18.0M | -29.4M | -8.40M | 70.5M | 151M | 328M | 404M | 368M | 366M | 362M |
| Cash & Short-term Investments | 67.2M | 86.4M | 58.4M | 117M | 114M | 228M | 158M | 111M | 156M | 180M |
| Total Debt | 391M | 76.7M | 74.3M | 183M | 366M | 394M | 452M | 477M | 404M | 394M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 34.4M | 46.0M | 56.0M | 121M | 121M | 184M | 77.3M | 168M | 196M | 128M |
| Capital Expenditure | 6.70M | 16.4M | 17.1M | 21.9M | 21.9M | 25.0M | 51.4M | 28.4M | 18.7M | 9.35M |
| Free Cash Flow | 27.7M | 29.6M | 38.9M | 99.5M | 99.5M | 159M | 25.9M | 140M | 178M | 118M |
| Ratios | ||||||||||
| ROE | - | - | - | 106.1% | 23.0% | 55.2% | 31.9% | 18.8% | 1.2% | 6.6% |
| ROA | -2.7% | -1.3% | 3.8% | 11.4% | 5.3% | 21.1% | 13.0% | 7.3% | 0.5% | 2.7% |
| Net Profit Margin | -3.9% | -1.6% | 3.8% | 11.1% | 4.5% | 19.9% | 12.9% | 7.9% | 0.6% | 3.1% |
| Debt to Equity | - | - | - | 2.59x | 2.43x | 1.20x | 1.12x | 1.30x | 1.10x | 1.09x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Dr. Martens plc dividends
- Dividend yield
- 4.85%
- Forward dividend
- 0.07 USD
- Payout ratio
- 105.0%
- Ex-dividend date
- Aug 28, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | GBP 25.0M | 0.05 | 105.0% |
| 2025 | GBP 9.50M | 0.02 | 211.1% |
| 2024 | GBP 57.8M | 0.12 | 83.5% |
| 2023 | GBP 58.4M | 0.12 | 45.3% |
| 2022 | GBP 12.2M | 0.02 | 6.7% |
| 2021 | GBP 51.3M | 0.10 | 147.8% |
| 2020 | GBP 12.2M | 0.07 | 16.3% |
| 2019 | GBP 12.2M | 0.05 | 70.9% |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Dr. Martens plc
Ownership data of Dr. Martens plc is not available yet.
Dr. Martens plc company profile
- Company name
- Dr. Martens plc
- Ticker
- DRMTY.US
- Exchange
- USA Stocks
- Sector
- Consumer Cyclical
- Industry
- Textiles, Apparel & Luxury Goods
- Employees
- 2,377
- Fiscal year end
- March
- Address
- 28 Jamestown Road, London, United Kingdom, NW1 7BY
- Phone
- 44 12 1415 7047
- Website
- drmartensplc.com
About Dr. Martens plc
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Dr. Martens plc management
10- Mr. Onyeije Ogueri NwokorieCEO & Executive Director · born 1970
- Mr. Giles Robert Bryant WilsonCFO & Director · born 1973
- Anna DuffietInterim Chief Operations Officer
- Graham CalderChief Technology Officer
- Ms. Bethany BarnesDirector of Investor Relations & Corporate Communications
- Ms. Katherine BellauChief Legal Officer & Company Secretary
- Ms. Bridget JolliffeChief People Officer
- Mr. Sean O'NeillChief Digital Officer
- Mr. Derek ChanPresident of APAC
- Mr. Mike StopforthChief Commercial Officer